{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:44:08Z","timestamp":1792133048137,"version":"4.4.0"},"reference-count":128,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","award":["C45237"],"award-info":[{"award-number":["C45237"]}],"id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Different guideline panels, and individuals, may make different decisions based in part on their preferences. Preferences for or against an intervention are viewed as a consequence of the relative importance people place on the expected or experienced health outcomes it incurs. These findings can then be considered as patient input when balancing effect estimates on benefits and harms reported by empirical evidence on the clinical effectiveness of screening programs.\u00a0This systematic review update examined the relative importance placed by patients on the potential benefits and harms of mammography-based breast cancer screening to inform an update to the 2018 Canadian Task Force on Preventive Health Care's guideline\u00a0on screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We screened all articles from our previous review (search December 2017) and\u00a0updated our searches to June 19, 2023 in MEDLINE, PsycINFO, and CINAHL. We also\u00a0screened grey literature, submissions by stakeholders, and reference lists. The target population was cisgender women and other adults assigned female at birth (including transgender men and nonbinary persons) aged\u00a0\u2265\u00a035 years and at average or moderately increased risk for breast cancer. Studies of patients with breast cancer were eligible for health-state utility data for relevant outcomes.\u00a0We sought three types of\u00a0data, directly through (i) disutilities of screening and curative treatment health states (measuring the impact of the outcome on one\u2019s health-related quality of life; utilities measured on a scale of 0 [death] to 1 [perfect health]), and (ii) other preference-based data, such as outcome trade-offs, and indirectly through (iii) the relative importance of benefits versus harms inferred from attitudes, intentions, and behaviors towards screening among patients\u00a0provided with estimates of the magnitudes of benefit(s) and harms(s). For screening, we used machine learning as one of the reviewers after at least 50% of studies had been reviewed in duplicate by humans; full-text selection used independent review by two humans. Data extraction and risk of bias assessments used a single reviewer with verification. Our main analysis for utilities used data from utility-based health-related quality of life tools (e.g., EQ-5D) in patients; a disutility value of about\u00a00.04 can be considered a minimally\u00a0important value for the Canadian public. When suitable, we pooled utilities and explored heterogeneity. Disutilities were calculated for screening health states and between different treatment states. Non-utility data were grouped into categories, based on outcomes compared (e.g. for trade-off data), participant age, and our judgements of the net benefit of screening portrayed by the studies. Thereafter, we compared and contrasted findings while considering sample sizes, risk of bias, subgroup findings and data on knowledge scores, and created summary statements for each data set. Certainty assessments followed GRADE guidance\u00a0for patient preferences and used consensus among at least two reviewers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>\n                      Eighty-two studies (38 on utilities) were included. The estimated disutilities were 0.07 for a positive screening result (moderate certainty), 0.03\u20130.04 for a false positive (FP; \u201cadditional testing\u201d resolved as negative for cancer) (low certainty), and 0.08 for untreated screen-detected cancer (moderate certainty) or (low certainty) an interval cancer. At \u226412 months, disutilities of mastectomy (vs. breast-conserving therapy), chemotherapy (vs. none) (low certainty), and radiation therapy (vs. none) (moderate certainty) were 0.02\u20130.03, 0.02\u20130.04, and little-to-none, respectively, though in each case findings\u00a0were somewhat limited in their applicability. Over the longer term, there was moderate certainty for little-to-no disutility from mastectomy versus breast-conserving surgery\/lumpectomy with radiation and from radiation. There was moderate certainty that a majority (&gt;50%) and possibly a large majority (&gt;75%) of women probably accept up to six cases of overdiagnosis to prevent one breast-cancer death; there was some uncertainty because of an indication that overdiagnosis was not fully understood by participants in some cases. Low certainty evidence suggested that a large majority may accept that screening may reduce breast-cancer but not all-cause mortality, at least when presented with relatively high rates of breast-cancer mortality reductions (\n                      <jats:italic>n<\/jats:italic>\n                      = 2; 2 and 5 fewer per 1000 screened), and at least a majority accept that to prevent one breast-cancer death at least a few hundred patients will receive a FP result and 10\u201315 will have a FP resolved through biopsy. An upper limit for an acceptable number of FPs was not evaluated.\u00a0When using data from studies assessing attitudes, intentions, and screening behaviors, across all age groups but most evident for women in their 40s, preferences reduced as the net benefit presented by study authors decreased in magnitude. In a relatively low net-benefit scenario, a majority of patients in their 40s may not weigh the benefits as greater than the harms from screening whereas for women in their 50s a large majority may prefer screening\u00a0(low certainty evidence\u00a0for both ages). There was moderate certainty that a large majority of women 50 years of\u00a0age and 50 to 69 years of age, who have usually experienced\u00a0screening, weigh the benefits as greater\u00a0than the harms from screening in a high net-benefit scenario. A large majority of patients aged 70\u201371 years who have recently screened\u00a0probably think the benefits outweigh the harms of continuing to screen. A majority of women in their mid-70s to early 80s may prefer to continue screening.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Evidence across a range of data sources on how informed patients value the potential outcomes from breast-cancer screening will be useful during decision-making for recommendations. The evidence suggests that all of the outcomes examined have importance to women of any age, that there is at least some and possibly substantial (among those in their 40s) variability across and within age groups about the acceptable magnitude of effects across outcomes, and that provision of easily understandable information on the likelihood of the outcomes may be necessary to enable informed decision making. Although studies came from a wide range of countries, there were limited data from Canada and about whether findings applied well across an ethnographically and\u00a0socioeconomically diverse population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      Protocol available at Open Science Framework\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/osf.io\/xngsu\/\">https:\/\/osf.io\/xngsu\/<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-024-02539-8","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T15:01:32Z","timestamp":1716908492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-7229","authenticated-orcid":false,"given":"Jennifer","family":"Pillay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Guitard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sholeh","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashiqur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Bialy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Gehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"3","key":"2539_CR1","doi-asserted-by":"publisher","first-page":"E123","DOI":"10.1503\/cmaj.131237","volume":"186","author":"HJ Sch\u00fcnemann","year":"2014","unstructured":"Sch\u00fcnemann HJ, Wiercioch W, Etxeandia I, Falavigna M, Santesso N, Mustafa R, et al. Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ. 2014;186(3):E123.","journal-title":"CMAJ"},{"issue":"1","key":"2539_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12955-017-0621-0","volume":"15","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Coello PA, Bro\u017cek J, Wiercioch W, Etxeandia-Ikobaltzeta I, Akl EA, et al. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes. 2017;15(1):52.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"2539_CR3","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.pec.2016.12.019","volume":"100","author":"CM Bastemeijer","year":"2017","unstructured":"Bastemeijer CM, Voogt L, van Ewijk JP, Hazelzet JA. What do patient values and preferences mean? A taxonomy based on a systematic review of qualitative papers. Patient Educ Couns. 2017;100(5):871\u201381.","journal-title":"Patient Educ Couns"},{"key":"2539_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jclinepi.2018.01.013","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Alonso-Coello P, Guyatt GH, Yepes-Nu\u00f1ez JJ, Akl EA, Hazlewood G, et al. GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-Risk of bias and indirectness. J Clin Epidemiol. 2019;111:94\u2013104.","journal-title":"J Clin Epidemiol."},{"key":"2539_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jclinepi.2018.05.011","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Coello PA, Guyatt GH, Yepes-Nu\u00f1ez JJ, Akl EA, Hazlewood G, et al. GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences-inconsistency, imprecision, and other domains. J Clin Epidemiol. 2019;111:83\u201393.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"2539_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1017\/S0266462300008461","volume":"5","author":"GW Torrance","year":"1989","unstructured":"Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 1989;5(4):559\u201375.","journal-title":"Int J Technol Assess Health Care"},{"issue":"4","key":"2539_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jval.2016.11.015","volume":"20","author":"NS McClure","year":"2017","unstructured":"McClure NS, Sayah FA, Xie F, Luo N, Johnson JA. Instrument-defined estimates of the minimally important difference for EQ-5D-5L index scores. Value Health. 2017;20(4):644\u201350.","journal-title":"Value Health"},{"issue":"2","key":"2539_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1046\/j.1369-6513.2001.00140.x","volume":"4","author":"TM Marteau","year":"2001","unstructured":"Marteau TM, Dormandy E, Michie S. A measure of informed choice. Health Expect. 2001;4(2):99\u2013108.","journal-title":"Health Expect"},{"issue":"2","key":"2539_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","volume":"50","author":"I Ajzen","year":"1991","unstructured":"Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179\u2013211.","journal-title":"Organ Behav Hum Decis Process"},{"issue":"8","key":"2539_CR10","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/03630240903496010","volume":"49","author":"F Griva","year":"2009","unstructured":"Griva F, Anagnostopoulos F, Madoglou S. Mammography screening and the theory of planned behavior: suggestions toward an extended model of prediction. Women Health. 2009;49(8):662\u201381.","journal-title":"Women Health"},{"issue":"49","key":"2539_CR11","doi-asserted-by":"publisher","first-page":"E1441","DOI":"10.1503\/cmaj.180463","volume":"190","author":"S Klarenbach","year":"2018","unstructured":"Klarenbach S, Sims-Jones N, Lewin G, Singh H, Th\u00e9riault G, Tonelli M, et al. Recommendations on screening for breast cancer in women aged 40\u201374 years who are not at increased risk for breast cancer. CMAJ. 2018;190(49):E1441-e1451.","journal-title":"CMAJ"},{"key":"2539_CR12","unstructured":"Canadian Task Force on Preventive Health Care. Canadian Task Force on Preventive Health Care Procedure Manual. 2022. https:\/\/canadiantaskforce.ca\/methods\/."},{"key":"2539_CR13","unstructured":"Pillay J, MacGregor T, Featherstone R, Hartling L. Breast Cancer Screening: Part B. Systematic Review on Women\u2019s Values and Preferences to Inform an Update of the Canadian Task Force on Preventive Health Care 2011 Guideline. 2018. \nhttps:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2018\/11\/Womens-Values-and-Preferences-on-Breast-Cancer-Screening_FINAL.pdf."},{"key":"2539_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"2539_CR15","unstructured":"United Nation\u2019s Development Programme. Human Development Index. Human Development Reports United Nations. 2022. \nhttps:\/\/hdr.undp.org\/content\/human-development-report-2021-22."},{"issue":"9290","key":"2539_CR16","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/S0140-6736(01)06449-2","volume":"358","author":"O Olsen","year":"2001","unstructured":"Olsen O, G\u00f8tzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet. 2001;358(9290):1340\u20132.","journal-title":"Lancet"},{"issue":"9198","key":"2539_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0140-6736(99)06065-1","volume":"355","author":"PC G\u00f8tzsche","year":"2000","unstructured":"G\u00f8tzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet. 2000;355(9198):129\u201334.","journal-title":"Lancet"},{"key":"2539_CR18","unstructured":"Distiller Inc. AI Screening. Ottawa, Canada: Evidence Partners. 2022. \nhttp:\/\/v2dis-help.evidencepartners.com\/1\/en\/topic\/ai-preview-and-rank."},{"key":"2539_CR19","doi-asserted-by":"publisher","unstructured":"Burns JK, Etherington C, Cheng-Boivin O, Boet S. Using an artificial intelligence tool can be as accurate as human assessors in level one screening for a systematic review. Health Info Libr J.\u00a02021;00:1\u201313. https:\/\/doi.org\/10.1111\/hir.12413.","DOI":"10.1111\/hir.12413"},{"issue":"1","key":"2539_CR20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12874-020-01129-1","volume":"20","author":"C Hamel","year":"2020","unstructured":"Hamel C, Kelly SE, Thavorn K, Rice DB, Wells GA, Hutton B. An evaluation of DistillerSR\u2019s machine learning-based prioritization tool for title\/abstract screening \u2013 impact on reviewer-relevant outcomes. BMC Med Res Methodol. 2020;20(1):256.","journal-title":"BMC Med Res Methodol"},{"key":"2539_CR21","unstructured":"Higgins JPT LT, Deeks JJ (editors). Chapter 6: Choosing effect measures and computing estimates of effect. In: Cochrane Handbook for Systematic Reviews of Interventions version 64 (updated August 2023). Edited by Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane; 203."},{"issue":"7497","key":"2539_CR22","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1136\/bmj.38398.469479.8F","volume":"330","author":"A Barratt","year":"2005","unstructured":"Barratt A, Howard K, Irwig L, Salkeld G, Houssami N. Model of outcomes of screening mammography: information to support informed choices. BMJ. 2005;330(7497):936.","journal-title":"BMJ"},{"issue":"11","key":"2539_CR23","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"MG Marmot","year":"2013","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205\u201340.","journal-title":"Br J Cancer"},{"issue":"3","key":"2539_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","volume":"22","author":"MH Murad","year":"2017","unstructured":"Murad MH, Mustafa RA, Sch\u00fcnemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85\u20137.","journal-title":"Evid Based Med"},{"key":"2539_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","volume":"119","author":"N Santesso","year":"2020","unstructured":"Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126\u201335.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"2539_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/0272989X15587676","volume":"35","author":"D Petrova","year":"2015","unstructured":"Petrova D, Garcia-Retamero R, Cokely ET. Understanding the harms and benefits of cancer screening: a model of factors that shape informed decision making. Med Decis Making. 2015;35(7):847\u201358.","journal-title":"Med Decis Making"},{"issue":"2","key":"2539_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/03007995.2016.1257983","volume":"33","author":"AA Ali","year":"2017","unstructured":"Ali AA, Xiao H, Tawk R, Campbell E, Semykina A, Montero AJ, et al. Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy. Curr Med Res Opin. 2017;33(2):391\u2013400.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"2539_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s11136-008-9353-2","volume":"17","author":"AE Bonomi","year":"2008","unstructured":"Bonomi AE, Boudreau DM, Fishman PA, Ludman E, Mohelnitzky A, Cannon EA, et al. Quality of life valuations of mammography screening. Qual Life Res. 2008;17(5):801\u201314.","journal-title":"Qual Life Res"},{"key":"2539_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ejca.2019.09.026","volume":"123","author":"HL Bromley","year":"2019","unstructured":"Bromley HL, Mann GB, Petrie D, Nickson C, Rea D, Roberts TE. Valuing preferences for treating screen detected ductal carcinoma in situ. Eur J Cancer. 2019;123:130\u20137.","journal-title":"Eur J Cancer"},{"issue":"7","key":"2539_CR30","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.clinthera.2021.04.020","volume":"43","author":"C Criscitiello","year":"2021","unstructured":"Criscitiello C, Spurden D, Piercy J, Rider A, Williams R, Mitra D, et al. Health-related quality of life among patients with HR+\/HER2- early breast cancer. Clin Ther. 2021;43(7):1228\u201344.","journal-title":"Clin Ther"},{"issue":"3","key":"2539_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3109\/02841861003610192","volume":"49","author":"M de Kok","year":"2010","unstructured":"de Kok M, Dirksen CD, Kessels AG, van der Weijden T, van de Velde CJ, Roukema JA, et al. Cost-effectiveness of a short stay admission programme for breast cancer surgery. Acta Oncol. 2010;49(3):338\u201346.","journal-title":"Acta Oncol"},{"key":"2539_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1477-7525-8-11","volume":"8","author":"PJ Domeyer","year":"2010","unstructured":"Domeyer PJ, Sergentanis TN, Zagouri F, Zografos GC. Health-related quality of life in vacuum-assisted breast biopsy: short-term effects, long-term effects and predictors. Health Qual Life Outcomes. 2010;8:11.","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"2539_CR33","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/anae.14856","volume":"74","author":"T Fujii","year":"2019","unstructured":"Fujii T, Shibata Y, Akane A, Aoki W, Sekiguchi A, Takahashi K, et al. A randomised controlled trial of pectoral nerve-2 (PECS 2) block vs. serratus plane block for chronic pain after mastectomy. Anaesthesia. 2019;74(12):1558\u201362.","journal-title":"Anaesthesia"},{"issue":"5","key":"2539_CR34","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/pon.4201","volume":"26","author":"LG Gordon","year":"2017","unstructured":"Gordon LG, DiSipio T, Battistutta D, Yates P, Bashford J, Pyke C, et al. Cost-effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial. Psychooncology. 2017;26(5):649\u201355.","journal-title":"Psychooncology"},{"issue":"10","key":"2539_CR35","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1007\/s11136-022-03157-4","volume":"31","author":"RE Haidari","year":"2022","unstructured":"Haidari RE, Anota A, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, et al. Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments. Qual Life Res. 2022;31(10):3077\u201385.","journal-title":"Qual Life Res"},{"issue":"5","key":"2539_CR36","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/bjc.2014.644","volume":"112","author":"PS Hall","year":"2015","unstructured":"Hall PS, Hamilton P, Hulme CT, Meads DM, Jones H, Newsham A, et al. Costs of cancer care for use in economic evaluation: a UK analysis of patient-level routine health system data. Br J Cancer. 2015;112(5):948\u201356.","journal-title":"Br J Cancer"},{"issue":"6","key":"2539_CR37","doi-asserted-by":"publisher","first-page":"e220631","DOI":"10.1001\/jamasurg.2022.0631","volume":"157","author":"SE Hanson","year":"2022","unstructured":"Hanson SE, Lei X, Roubaud MS, DeSnyder SM, Caudle AS, Shaitelman SF, et al. Long-term quality of life in patients with breast cancer after breast conservation vs mastectomy and reconstruction. JAMA Surg. 2022;157(6):e220631.","journal-title":"JAMA Surg"},{"key":"2539_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12955-015-0399-x","volume":"13","author":"SH Kim","year":"2015","unstructured":"Kim SH, Jo MW, Lee JW, Lee HJ, Kim JK. Validity and reliability of EQ-5D-3L for breast cancer patients in Korea. Health Qual Life Outcomes. 2015;13:203.","journal-title":"Health Qual Life Outcomes."},{"issue":"3","key":"2539_CR39","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jval.2016.10.013","volume":"20","author":"FM Knuttel","year":"2017","unstructured":"Knuttel FM, van den Bosch MAAJ, Young-Afat DA, Emaus MJ, van den Bongard DHJG, Witkamp AJ, Verkooijen HM. Patient preferences for minimally invasive and open locoregional treatment for early-stage breast cancer. Value Health. 2017;20(3):474\u201380.","journal-title":"Value Health"},{"issue":"1","key":"2539_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PRS.0000000000006887","volume":"146","author":"CAE Kouwenberg","year":"2020","unstructured":"Kouwenberg CAE, de Ligt KM, Kranenburg LW, Rakhorst H, de Leeuw D, Siesling S, Busschbach JJ, Mureau MAM. Long-term health-related qQuality of life after four common surgical treatment options for breast cancer and the effect of complications: a retrospective patient-reported survey among 1871 patients. Plast Reconstr Surg. 2020;146(1):1\u201313.","journal-title":"Plast Reconstr Surg"},{"issue":"12","key":"2539_CR41","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1245\/s10434-018-6729-6","volume":"25","author":"M Lagendijk","year":"2018","unstructured":"Lagendijk M, van Egdom LSE, van Veen FEE, Vos EL, Mureau MAM, van Leeuwen N, et al. Patient-reported outcome measures may add value in breast cancer surgery. Ann Surg Onco. 2018;25(12):3563\u201371.","journal-title":"Ann Surg Onco"},{"issue":"4","key":"2539_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/tbj.12980","volume":"24","author":"M Lagendijk","year":"2018","unstructured":"Lagendijk M, Vos EL, Nieboer D, Verhoef C, Corten EML, Koppert LB. Evaluation of cosmetic outcome following breast-conserving therapy in trials: panel versus digitalized analysis and the role of PROMs. Breast J. 2018;24(4):519\u201325.","journal-title":"Breast J"},{"issue":"3","key":"2539_CR43","doi-asserted-by":"publisher","first-page":"e012187","DOI":"10.1136\/bmjopen-2016-012187","volume":"7","author":"AM May","year":"2017","unstructured":"May AM, Bosch MJC, Velthuis MJ, van der Wall E, Steins Bisschop CN, Los M, et al. Cost- effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study. BMJ Open. 2017;7(3):e012187.","journal-title":"BMJ Open"},{"issue":"5","key":"2539_CR44","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.2196\/jmir.3421","volume":"16","author":"YH Min","year":"2014","unstructured":"Min YH, Lee JW, Shin YW, Jo MW, Sohn G, Lee JH, et al. Daily collection of self-reporting sleep disturbance data via a smartphone app in breast cancer patients receiving chemotherapy: a feasibility study. J Med Internet Res. 2014;16(5):e135.","journal-title":"J Med Internet Res"},{"issue":"4","key":"2539_CR45","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s11136-022-03327-4","volume":"32","author":"C Miret","year":"2023","unstructured":"Miret C, Orive M, Sala M, Garcia-Gutierrez S, Sarasqueta C, Legarreta MJ, et al. Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non- metastatic breast cancer at diagnosis and 2 years after. Qual Life Res. 2023;32(4):989\u20131003.","journal-title":"Qual Life Res"},{"issue":"3","key":"2539_CR46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/bjs\/znaa125","volume":"108","author":"JL Morgan","year":"2021","unstructured":"Morgan JL, Shrestha A, Reed MWR, Herbert E, Bradburn M, Walters SJ, et al. Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes. Br J Surg. 2021;108(3):315\u201325.","journal-title":"Br J Surg"},{"issue":"4","key":"2539_CR47","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12282-012-0402-x","volume":"21","author":"D Moro-Valdezate","year":"2014","unstructured":"Moro-Valdezate D, Buch-Villa E, Peir\u00f3 S, Morales-Monsalve MD, Caballero-G\u00e1rate A, Mart\u00ednez-Agull\u00f3 \u00c1, et al. Factors associated with health-related quality of life in a cohort of Spanish breast cancer patients. Breast Cancer. 2014;21(4):442\u201352.","journal-title":"Breast Cancer"},{"issue":"4","key":"2539_CR48","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11136-021-03017-7","volume":"31","author":"N Moshina","year":"2022","unstructured":"Moshina N, Falk RS, Botteri E, Larsen M, Akslen LA, Cairns JA, et al. Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway. Qual Life Res. 2022;31(4):1057\u201368.","journal-title":"Qual Life Res"},{"issue":"7","key":"2539_CR49","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1089\/tmj.2022.0360","volume":"29","author":"HY Park","year":"2023","unstructured":"Park HY, Nam KE, Lim JY, Yeo SM, Lee JI, Hwang JH. Real-time interactive digital health care system for postoperative breast cancer patients: a randomized controlled trial. Telemed J E Health. 2023;29(7):1057\u201367.","journal-title":"Telemed J E Health"},{"issue":"10","key":"2539_CR50","doi-asserted-by":"publisher","first-page":"e0239803","DOI":"10.1371\/journal.pone.0239803","volume":"15","author":"G Porciello","year":"2020","unstructured":"Porciello G, Montagnese C, Crispo A, Grimaldi M, Libra M, Vitale S, et al. Mediterranean diet and quality of life in women treated for breast cancer: a baseline analysis of DEDiCa multicentre trial. PloS One. 2020;15(10):e0239803.","journal-title":"PloS One"},{"issue":"5","key":"2539_CR51","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1080\/0284186X.2017.1400683","volume":"57","author":"M Rautalin","year":"2018","unstructured":"Rautalin M, F\u00e4rkkil\u00e4 N, Sintonen H, Saarto T, Taari K, Jahkola T, et al. Health-related quality of life in different states of breast cancer - comparing different instruments. Acta Oncol. 2018;57(5):622\u20138.","journal-title":"Acta Oncol"},{"issue":"7","key":"2539_CR52","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.ejso.2021.02.006","volume":"47","author":"M Rautalin","year":"2021","unstructured":"Rautalin M, Jahkola T, Roine RP. Surgery and health-related quality of life - a prospective follow up study on breast cancer patients in Finland. Eur J Surg Oncol. 2021;47(7):1581\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"2539_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41416-021-01388-9","volume":"125","author":"A Ring","year":"2021","unstructured":"Ring A, Battisti NML, Reed MWR, Herbert E, Morgan JL, Bradburn M, et al. Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer. Br J Cancer. 2021;125(2):209\u201319.","journal-title":"Br J Cancer"},{"issue":"2","key":"2539_CR54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.21873\/invivo.11821","volume":"34","author":"E Roine","year":"2020","unstructured":"Roine E, Sintonen H, Kellokumpu-Lehtinen PL, Penttinen H, Utriainen M, Vehmanen L, et al. Health-related quality of life of breast cancer survivors attending an exercise intervention study: a five-year follow-up. In Vivo. 2020;34(2):667\u201374.","journal-title":"In Vivo"},{"issue":"12","key":"2539_CR55","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1111\/j.1525-1497.2006.00609.x","volume":"21","author":"MD Schleinitz","year":"2006","unstructured":"Schleinitz MD, DePalo D, Blume J, Stein M. Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med. 2006;21(12):1253\u201360.","journal-title":"J Gen Intern Med"},{"key":"2539_CR56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vhri.2014.01.003","volume":"3","author":"D Songtish","year":"2014","unstructured":"Songtish D, Praditsitthikorn N, Teerawattananon Y. A cost-utility analysis comparing standard axillary lymph node dissection with sentinel lymph node biopsy in patients with early stage breast cancer in thailand. Value Health Reg Issues. 2014;3:59\u201366.","journal-title":"Value Health Reg Issues"},{"issue":"4","key":"2539_CR57","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ijrobp.2017.11.047","volume":"100","author":"CW Swanick","year":"2018","unstructured":"Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Smith GL, et al. Long-term patient- reported outcomes in older breast cancer survivors: a population-based survey study. Int J Radiat Oncol Biol Phys. 2018;100(4):882\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"2539_CR58","first-page":"439","volume":"74","author":"K Tanaka","year":"2019","unstructured":"Tanaka K, Tachi T, Hori A, Osawa T, Nagaya K, Makino T, et al. Cost utility analysis of pharmacist counseling care for breast cancer chemotherapy outpatients. Pharmazie. 2019;74(7):439\u201342.","journal-title":"Pharmazie"},{"issue":"5","key":"2539_CR59","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.17269\/cjph.105.4463","volume":"105","author":"JM Timmers","year":"2014","unstructured":"Timmers JM, Damen JA, Pijnappel RM, Verbeek AL, den Heeten GJ, Adang EM, et al. Cost- effectiveness of non-invasive assessment in the Dutch breast cancer screening program versus usual care: a randomized controlled trial. Can J Public Health. 2014;105(5):e342-47.","journal-title":"Can J Public Health"},{"issue":"6","key":"2539_CR60","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1001\/jamainternmed.2014.981","volume":"174","author":"AN Tosteson","year":"2014","unstructured":"Tosteson AN, Fryback DG, Hammond CS, Hanna LG, Grove MR, Brown M, et al. Consequences of false-positive screening mammograms. JAMA Intern Med. 2014;174(6):954\u201361.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"2539_CR61","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s11764-022-01165-4","volume":"17","author":"TXM Tran","year":"2023","unstructured":"Tran TXM, Jung SY, Lee EG, Cho H, Cho J, Lee E, et al. Long-term trajectory of postoperative health-related quality of life in young breast cancer patients: a 15-year follow- up study. J Cancer Surviv. 2023;17(5):1416\u201326.","journal-title":"J Cancer Surviv"},{"issue":"11","key":"2539_CR62","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/S1470-2045(18)30515-1","volume":"19","author":"G Velikova","year":"2018","unstructured":"Velikova G, Williams LJ, Willis S, Dixon JM, Loncaster J, Hatton M, et al. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial. Lancet Oncol. 2018;19(11):1516\u201329.","journal-title":"Lancet Oncol"},{"issue":"5","key":"2539_CR63","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/pon.5065","volume":"28","author":"D Youens","year":"2019","unstructured":"Youens D, Halkett G, Wright C, O\u2019Connor M, Schofield P, Jefford M, et al. Assessing the cost-effectiveness of RT Prepare: a radiation therapist-delivered intervention for reducing psychological distress prior to radiotherapy. Psychooncology. 2019;28(5):1110\u20138.","journal-title":"Psychooncology"},{"issue":"2","key":"2539_CR64","first-page":"209","volume":"59","author":"T \u017digman","year":"2020","unstructured":"\u017digman T, Luk\u0161a I, Mihaljevi\u0107 G, \u017darkovi\u0107 M, Kirac I, Vrdoljak DV, et al. Defining health- related quality of life in localized and advanced stages of breast cancer - the first step towards hereditary cancer genetic counseling. Acta Clin Croat. 2020;59(2):209\u201315.","journal-title":"Acta Clin Croat"},{"key":"2539_CR65","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.breast.2021.06.012","volume":"59","author":"E Roine","year":"2021","unstructured":"Roine E, Sintonen H, Kellokumpu-Lehtinen PL, Penttinen H, Utriainen M, Vehmanen L, et al. Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise study. Breast. 2021;59:110\u20136.","journal-title":"Breast"},{"key":"2539_CR66","unstructured":"Alberta PROMS and EQ-5D Research and Support Unit. Alberta Population Norms for EQ- 5D-5L. 2018. Available at: \nhttps:\/\/sites.google.com\/ualberta.ca\/apersu\/about-eq-5d\/eq-5d-population-norms."},{"issue":"5","key":"2539_CR67","doi-asserted-by":"publisher","first-page":"e019852","DOI":"10.1136\/bmjopen-2017-019852","volume":"8","author":"JM Baena-Ca\u00f1ada","year":"2018","unstructured":"Baena-Ca\u00f1ada JM, Luque-Ribelles V, Quilez-Cutillas A, Rosado-Varela P, Benitez- Rodriguez E, Marquez-Calderon S, et al. How a deliberative approach includes women in the decisions of screening mammography: a citizens\u2019 jury feasibility study in Andalusia, Spain. BMJ Open. 2018;8(5):e019852.","journal-title":"BMJ Open"},{"issue":"12","key":"2539_CR68","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/cam4.525","volume":"4","author":"JM Baena-Ca\u00f1ada","year":"2015","unstructured":"Baena-Ca\u00f1ada JM, Rosado-Varela P, Exp\u00f3sito-\u00c1lvarez I, Gonz\u00e1lez-Guerrero M, Nieto-Vera J, Ben\u00edtez-Rodr\u00edguez E. Using an informed consent in mammography screening: a randomized trial. Cancer Med. 2015;4(12):1923\u201332.","journal-title":"Cancer Med"},{"issue":"11","key":"2539_CR69","doi-asserted-by":"publisher","first-page":"e0142316","DOI":"10.1371\/journal.pone.0142316","volume":"10","author":"EM Berens","year":"2015","unstructured":"Berens EM, Reder M, Razum O, Kolip P, Spallek J. Informed choice in the german mammography screening program by education and migrant status: survey among first-time invitees. PLoS One. 2015;10(11):e0142316.","journal-title":"PLoS One"},{"issue":"9","key":"2539_CR70","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jval.2020.06.004","volume":"23","author":"M Bilger","year":"2020","unstructured":"Bilger M, \u00d6zdemir S, Finkelstein EA. Demand for cancer screening services: results from randomized controlled discrete choice experiments. Value Health. 2020;23(9):1246\u201355.","journal-title":"Value Health"},{"issue":"11","key":"2539_CR71","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.18632\/oncotarget.7332","volume":"7","author":"A Bourmaud","year":"2016","unstructured":"Bourmaud A, Soler-Michel P, Oriol M, Regnier V, Tinquaut F, Nourissat A, et al. Decision aid on breast cancer screening reduces attendance rate: results of a large-scale, randomized, controlled study by the DECIDEO group. Oncotarget. 2016;7(11):12885\u201392.","journal-title":"Oncotarget"},{"key":"2539_CR72","doi-asserted-by":"crossref","unstructured":"Braithwaite D, Chicaiza A, Lopez K, Lin KW, Mishori R, Karanth SD, et al. Clinician and patient perspectives on screening mammography among women age 75 and older: a pilot study of a novel decision aid. PEC Innov. 2023.","DOI":"10.1016\/j.pecinn.2023.100132"},{"issue":"9","key":"2539_CR73","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.pec.2021.02.020","volume":"104","author":"T Cadet","year":"2021","unstructured":"Cadet T, Aliberti G, Karamourtopoulos M, Jacobson A, Gilliam EA, Primeau S, et al. Evaluation of a mammography decision aid for women 75 and older at risk for lower health literacy in a pretest-posttest trial. Patient Educ Couns. 2021;104(9):2344\u201350.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"2539_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1467-842X.2005.tb00752.x","volume":"29","author":"C Davey","year":"2005","unstructured":"Davey C, White V, Gattellari M, Ward JE. Reconciling population benefits and women\u2019s individual autonomy in mammographic screening: in-depth interviews to explore women\u2019s views about \u201cinformed choice.\u201d Aust N Z J Public Health. 2005;29(1):69\u201377.","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"2539_CR75","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s12885-017-3596-7","volume":"17","author":"SM Driedger","year":"2017","unstructured":"Driedger SM, Annable G, Brouwers M, Turner D, Maier R. Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions. BMC Cancer. 2017;17(1):647.","journal-title":"BMC Cancer"},{"issue":"1","key":"2539_CR76","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12911-017-0423-7","volume":"17","author":"EB Elkin","year":"2017","unstructured":"Elkin EB, Pocus VH, Mushlin AI, Cigler T, Atoria CL, Polaneczky MM. Facilitating informed decisions about breast cancer screening: development and evaluation of a web- based decision aid for women in their 40s. BMC Med Inform Decis Mak. 2017;17(1):29.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"2539_CR77","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2383050852","volume":"238","author":"MA Ganott","year":"2006","unstructured":"Ganott MA, Sumkin JH, King JL, Klym AH, Catullo VJ, Cohen CS, Gur D. Screening mammography: do women prefer a higher recall rate given the possibility of earlier detection of cancer? Radiology. 2006;238(3):793\u2013800.","journal-title":"Radiology"},{"key":"2539_CR78","doi-asserted-by":"crossref","unstructured":"Gummersbach E, in der Schmitten J, Mortsiefer A, Abholz HH, Wegscheider K, Pentzek M. Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content. Dtsch Arztebl Int. 2015;112(5):61-8.","DOI":"10.3238\/arztebl.2015.0061"},{"issue":"3","key":"2539_CR79","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1017\/S0266462300102089","volume":"16","author":"D Gyrd-Hansen","year":"2000","unstructured":"Gyrd-Hansen D. Cost-benefit analysis of mammography screening in Denmark based on discrete ranking data. Int J Technol Assess Health Care. 2000;16(3):811\u201321.","journal-title":"Int J Technol Assess Health Care"},{"issue":"6","key":"2539_CR80","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4065\/81.6.783","volume":"81","author":"CP Haakenson","year":"2006","unstructured":"Haakenson CP, Vickers KS, Cha SS, Vachon CM, Thielen JM, Kircher KJ, et al. Efficacy of a simple, low-cost educational intervention in improving knowledge about risks and benefits of screening mammography. Mayo Clin Proc. 2006;81(6):783\u201391.","journal-title":"Mayo Clin Proc"},{"key":"2539_CR81","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13104-015-1327-1","volume":"8","author":"MJ Henriksen","year":"2015","unstructured":"Henriksen MJ, Guassora AD, Brodersen J. Preconceptions influence women\u2019s perceptions of information on breast cancer screening: a qualitative study. BMC Res Notes. 2015;8:404.","journal-title":"BMC Res Notes"},{"issue":"9978","key":"2539_CR82","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(15)60123-4","volume":"385","author":"J Hersch","year":"2015","unstructured":"Hersch J, Barratt A, Jansen J, Irwig L, McGeechan K, Jacklyn G, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Lancet. 2015;385(9978):1642\u201352.","journal-title":"Lancet"},{"key":"2539_CR83","doi-asserted-by":"publisher","first-page":"f158","DOI":"10.1136\/bmj.f158","volume":"346","author":"J Hersch","year":"2013","unstructured":"Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women\u2019s views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346:f158.","journal-title":"BMJ"},{"issue":"3","key":"2539_CR84","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1148\/radiol.2493072176","volume":"249","author":"NF Jafri","year":"2008","unstructured":"Jafri NF, Ayyala RS, Ozonoff A, Jordan-Gray J, Slanetz PJ. Screening mammography: does ethnicity influence patient preferences for higher recall rates given the potential for earlier detection of breast cancer? Radiology. 2008;249(3):785\u201391.","journal-title":"Radiology"},{"issue":"3","key":"2539_CR85","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1006\/pmed.1999.0620","volume":"30","author":"VA Lawrence","year":"2000","unstructured":"Lawrence VA, Streiner D, Hazuda HP, Naylor R, Levine M, Gafni A. A cross-cultural consumer-based decision aid for screening mammography. Prev Med. 2000;30(3):200\u20138.","journal-title":"Prev Med"},{"issue":"16","key":"2539_CR86","doi-asserted-by":"publisher","first-page":"10426","DOI":"10.3390\/ijerph191610426","volume":"19","author":"C Laza-Vasquez","year":"2022","unstructured":"Laza-Vasquez C, Martinez-Alonso M, Forne-Izquierdo C, Vilaplana-Mayoral J, Cruz-Esteve I, Sanchez-Lopez I, et al. Feasibility and accceptability of personalized breast cancer screening (DECIDO Study): a single-arm proof-of-concept trial. Int J Environ Res Public Health. 2022;19(16):10426.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"2539_CR87","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1525-1497.2003.21152.x","volume":"18","author":"CL Lewis","year":"2003","unstructured":"Lewis CL, Pignone MP, Sheridan SL, Downs SM, Kinsinger LS. A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old. J Gen Intern Med. 2003;18(11):875\u201383.","journal-title":"J Gen Intern Med"},{"issue":"19","key":"2539_CR88","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1001\/archinte.167.19.2039","volume":"167","author":"E Mathieu","year":"2007","unstructured":"Mathieu E, Barratt A, Davey HM, McGeechan K, Howard K, Houssami N. Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. Arch Intern Med. 2007;167(19):2039\u201346.","journal-title":"Arch Intern Med"},{"issue":"1","key":"2539_CR89","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pec.2010.01.001","volume":"81","author":"E Mathieu","year":"2010","unstructured":"Mathieu E, Barratt AL, McGeechan K, Davey HM, Howard K, Houssami N. Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. Patient Educ Couns. 2010;81(1):63\u201372.","journal-title":"Patient Educ Couns"},{"issue":"4","key":"2539_CR90","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/j.1369-7625.2008.00514.x","volume":"11","author":"L Nekhlyudov","year":"2008","unstructured":"Nekhlyudov L, Li R, Fletcher SW. Informed decision making before initiating screening mammography: does it occur and does it make a difference? Health Expect. 2008;11(4):366\u201375.","journal-title":"Health Expect"},{"issue":"6","key":"2539_CR91","doi-asserted-by":"publisher","first-page":"e022138","DOI":"10.1136\/bmjopen-2018-022138","volume":"8","author":"MR Pappadis","year":"2018","unstructured":"Pappadis MR, Volk RJ, Krishnan S, Weller SC, Jaramillo E, Hoover DS, et al. Perceptions of overdetection of breast cancer among women 70 years of age and older in the USA: a mixed- methods analysis. BMJ Open. 2018;8(6):e022138.","journal-title":"BMJ Open"},{"issue":"3","key":"2539_CR92","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.healthpol.2007.08.007","volume":"85","author":"C Paul","year":"2008","unstructured":"Paul C, Nicholls R, Priest P, McGee R. Making policy decisions about population screening for breast cancer: the role of citizens\u2019 deliberation. Health Policy. 2008;85(3):314\u201320.","journal-title":"Health Policy"},{"issue":"3","key":"2539_CR93","doi-asserted-by":"publisher","first-page":"e0214057","DOI":"10.1371\/journal.pone.0214057","volume":"14","author":"MJ Perez-Lacasta","year":"2019","unstructured":"Perez-Lacasta MJ, Martinez-Alonso M, Garcia M, Sala M, Perestelo-Perez L, Vidal C, et al. Effect of information about the benefits and harms of mammography on women\u2019s decision making: the InforMa randomised controlled trial. PloS One. 2019;14(3):e0214057.","journal-title":"PloS One"},{"issue":"12","key":"2539_CR94","doi-asserted-by":"publisher","first-page":"e0189148","DOI":"10.1371\/journal.pone.0189148","volume":"12","author":"M Reder","year":"2017","unstructured":"Reder M, Kolip P. Does a decision aid improve informed choice in mammography screening? Results from a randomised controlled trial. PloS One. 2017;12(12):e0189148.","journal-title":"PloS One"},{"issue":"5","key":"2539_CR95","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41416-020-0935-2","volume":"123","author":"A Roberto","year":"2020","unstructured":"Roberto A, Colombo C, Candiani G, Satolli R, Giordano L, Jaramillo L, et al. A dynamic web-based decision aid to improve informed choice in organised breast cancer screening. A pragmatic randomised trial in Italy. Br J Cancer. 2020;123(5):714\u201321.","journal-title":"Br J Cancer"},{"issue":"1","key":"2539_CR96","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1370\/afm.1996","volume":"15","author":"BG Saver","year":"2017","unstructured":"Saver BG, Mazor KM, Luckmann R, Cutrona SL, Hayes M, Gorodetsky T, et al. Persuasive interventions for controversial cancer screening recommendations: testing a novel approach to help patients make evidence-based decisions. Ann Fam Med. 2017;15(1):48\u201355.","journal-title":"Ann Fam Med"},{"issue":"3","key":"2539_CR97","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.amepre.2020.04.014","volume":"59","author":"MA Schonberg","year":"2020","unstructured":"Schonberg MA, Davis RB, Karamourtopoulos MC, Pinheiro A, Sternberg SB, Jacobson AR, et al. A pre-test-post-test trial of a breast cancer risk report for women in their 40s. Am J Prev Med. 2020;59(3):343\u201354.","journal-title":"Am J Prev Med"},{"issue":"3","key":"2539_CR98","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1001\/jamainternmed.2013.13639","volume":"174","author":"MA Schonberg","year":"2014","unstructured":"Schonberg MA, Hamel MB, Davis RB, Griggs MC, Wee CC, Fagerlin A, et al. Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med. 2014;174(3):417\u201324.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"2539_CR99","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamainternmed.2020.0440","volume":"180","author":"MA Schonberg","year":"2020","unstructured":"Schonberg MA, Kistler CE, Pinheiro A, Jacobson AR, Aliberti GM, Karamourtopoulos M, et al. Effect of a mammography screening decision aid for women 75 years and older: a cluster randomized clinical trial. JAMA Intern Med. 2020;180(6):831\u201342.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"2539_CR100","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/ewjm.173.5.307","volume":"173","author":"LM Schwartz","year":"2000","unstructured":"Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG. US women\u2019s attitudes to false- positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey. West J Med. 2000;173(5):307\u201312.","journal-title":"West J Med"},{"issue":"10","key":"2539_CR101","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.pec.2016.05.005","volume":"99","author":"HH Seitz","year":"2016","unstructured":"Seitz HH, Gibson L, Skubisz C, Forquer H, Mello S, Schapira MM, et al. Effects of a risk- based online mammography intervention on accuracy of perceived risk and mammography intentions. Patient Educ Couns. 2016;99(10):1647\u201356.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"2539_CR102","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jval.2017.07.003","volume":"21","author":"J Sicsic","year":"2018","unstructured":"Sicsic J, Pelletier-Fleury N, Moumjid N. Women\u2019s benefits and harms trade-offs in breast cancer screening: results from a discrete-choice experiment. Value Health. 2018;21(1):78\u201388.","journal-title":"Value Health"},{"issue":"1","key":"2539_CR103","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/0272989X19886886","volume":"40","author":"A Stiggelbout","year":"2020","unstructured":"Stiggelbout A, Copp T, Jacklyn G, Jansen J, Liefers GJ, McCaffery K, Hersch J. Women\u2019s acceptance of overdetection in breast cancer screening: can we assess harm-benefit tradeoffs? Med Decis Making. 2020;40(1):42\u201351.","journal-title":"Med Decis Making"},{"key":"2539_CR104","doi-asserted-by":"crossref","unstructured":"Toledo-Ch\u00e1varri A, Ru\u00e9 M, Codern-Bov\u00e9 N, Carles-Lavila M, Perestelo-P\u00e9rez L, P\u00e9rez- Lacasta MJ, et al. A qualitative study on a decision aid for breast cancer screening: views from women and health professionals. Eur J Cancer Care (Engl). 2017;26(3):e12660.","DOI":"10.1111\/ecc.12660"},{"issue":"3","key":"2539_CR105","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/0272989X211039743","volume":"42","author":"KD Valentine","year":"2022","unstructured":"Valentine KD, Wegier P, Shaffer VA, Scherer LD. The impact of 4 risk communication interventions on cancer screening preferences and knowledge. Med Decis Mak. 2022;42(3):387\u201397.","journal-title":"Med Decis Mak"},{"key":"2539_CR106","doi-asserted-by":"publisher","first-page":"h980","DOI":"10.1136\/bmj.h980","volume":"350","author":"A Van den Bruel","year":"2015","unstructured":"Van den Bruel A, Jones C, Yang Y, Oke J, Hewitson P. People\u2019s willingness to accept overdetection in cancer screening: population survey. BMJ. 2015;350:h980.","journal-title":"BMJ"},{"issue":"4","key":"2539_CR107","doi-asserted-by":"publisher","first-page":"e002703","DOI":"10.1136\/bmjopen-2013-002703","volume":"3","author":"J Waller","year":"2013","unstructured":"Waller J, Douglas E, Whitaker KL, Wardle J. Women\u2019s responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study. BMJ Open. 2013;3(4):e002703.","journal-title":"BMJ Open"},{"issue":"9","key":"2539_CR108","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/bjc.2014.482","volume":"111","author":"J Waller","year":"2014","unstructured":"Waller J, Whitaker KL, Winstanley K, Power E, Wardle J. A survey study of women\u2019s responses to information about overdiagnosis in breast cancer screening in Britain. Br J Cancer. 2014;111(9):1831\u20135.","journal-title":"Br J Cancer"},{"issue":"8","key":"2539_CR109","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.pec.2015.04.014","volume":"98","author":"IO Wong","year":"2015","unstructured":"Wong IO, Lam WW, Wong CN, Cowling BJ, Leung GM, Fielding R. Towards informed decisions on breast cancer screening: development and pilot testing of a decision aid for Chinese women. Patient Educ Couns. 2015;98(8):961\u20139.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"2539_CR110","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10549-006-9270-4","volume":"101","author":"H Yasunaga","year":"2007","unstructured":"Yasunaga H, Ide H, Imamura T, Ohe K. Women\u2019s anxieties caused by false positives in mammography screening: a contingent valuation survey. Breast Cancer Res Treat. 2007;101(1):59\u201364.","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"2539_CR111","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1002\/cncr.33857","volume":"127","author":"T Cadet","year":"2021","unstructured":"Cadet T, Pinheiro A, Karamourtopoulos M, Jacobson AR, Aliberti GM, Kistler CE, et al. Effects by educational attainment of a mammography screening patient decision aid for women aged 75 years and older. Cancer. 2021;127(23):4455\u201363.","journal-title":"Cancer"},{"issue":"11","key":"2539_CR112","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/jnci\/djab083","volume":"113","author":"J Hersch","year":"2021","unstructured":"Hersch J, Barratt A, McGeechan K, Jansen J, Houssami N, Dhillon H, et al. Informing women about overdetection in breast cancer screening: two-year outcomes from a randomized trial. J Natl Cancer Inst. 2021;113(11):1523\u201330.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"2539_CR113","doi-asserted-by":"publisher","first-page":"e016246","DOI":"10.1136\/bmjopen-2017-016246","volume":"7","author":"J Hersch","year":"2017","unstructured":"Hersch J, McGeechan K, Barratt A, Jansen J, Irwig L, Jacklyn G, et al. How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial. BMJ Open. 2017;7(10):e016246.","journal-title":"BMJ Open"},{"issue":"2","key":"2539_CR114","doi-asserted-by":"publisher","first-page":"e0281454","DOI":"10.1371\/journal.pone.0281454","volume":"18","author":"MB L\u00f3pez-Panisello","year":"2023","unstructured":"L\u00f3pez-Panisello MB, P\u00e9rez-Lacasta MJ, Ru\u00e9 M, Carles-Lavila M. Factors influencing intention to participate in breast cancer screening An exploratory structural model. PloS One. 2023;18(2):e0281454.","journal-title":"PloS One"},{"issue":"9","key":"2539_CR115","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1080\/08870446.2010.481718","volume":"26","author":"P Norman","year":"2011","unstructured":"Norman P, Cooper Y. The theory of planned behaviour and breast self-examination: assessing the impact of past behaviour, context stability and habit strength. Psychol Health. 2011;26(9):1156\u201372.","journal-title":"Psychol Health"},{"key":"2539_CR116","doi-asserted-by":"crossref","unstructured":"Rutter DR. Attendance and reattendance for breast cancer screening: a prospective 3-year test of the Theory of Planned Behaviour. Br J Health Psychol. 2000;5(Part 1):1-13.","DOI":"10.1348\/135910700168720"},{"key":"2539_CR117","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.socscimed.2019.03.028","volume":"228","author":"HL Bromley","year":"2019","unstructured":"Bromley HL, Petrie D, Mann GB, Nickson C, Rea D, Roberts TE. Valuing the health states associated with breast cancer screening programmes: a systematic review of economic measures. Soc Sci Med. 2019;228:142\u201354.","journal-title":"Soc Sci Med"},{"issue":"24","key":"2539_CR118","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.3390\/ijerph17249412","volume":"17","author":"JR Gong","year":"2020","unstructured":"Gong JR, Han J, Lee D, Bae S. A meta-regression analysis of utility weights for breast cancer: the power of patients\u2019 experience. Int J Environ Res Public Health. 2020;17(24):9412.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"2539_CR119","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1177\/0272989X211065471","volume":"42","author":"MN Kaur","year":"2022","unstructured":"Kaur MN, Yan J, Klassen AF, David JP, Pieris D, Sharma M, et al. A systematic literature review of health utility values in breast cancer. Med Decis Making. 2022;42(5):704\u201319.","journal-title":"Med Decis Making"},{"issue":"7","key":"2539_CR120","doi-asserted-by":"publisher","first-page":"e0220148","DOI":"10.1371\/journal.pone.0220148","volume":"14","author":"L Li","year":"2019","unstructured":"Li L, Severens JLH, Mandrik O. Disutility associated with cancer screening programs: a systematic review. PloS One. 2019;14(7):e0220148.","journal-title":"PloS One"},{"issue":"8","key":"2539_CR121","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10198-021-01335-8","volume":"22","author":"MM Pourrahmat","year":"2021","unstructured":"Pourrahmat MM, Kim A, Kansal AR, Hux M, Pushkarna D, Fazeli MS, et al. Health state utility values by cancer stage: a systematic literature review. Eur J Health Econ. 2021;22(8):1275\u201388.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"2539_CR122","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12955-022-02067-w","volume":"20","author":"Y Wang","year":"2022","unstructured":"Wang Y, Gavan SP, Steinke D, Cheung KL, Chen LC. The impact of age on health utility values for older women with early-stage breast cancer: a systematic review and meta-regression. Health Qual Life Outcomes. 2022;20(1):169.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"2539_CR123","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1245\/s10434-019-07160-x","volume":"26","author":"AY Yoon","year":"2019","unstructured":"Yoon AY, Bozzuto L, Seto AJ, Fisher CS, Chatterjee A. A systematic review of utility score assessments in the breast surgery cost-analysis literature. Ann Surg Oncol. 2019;26(5):1190\u2013201.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2539_CR124","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamainternmed.2014.6016","volume":"175","author":"TC Hoffmann","year":"2015","unstructured":"Hoffmann TC, Del Mar C. Patients\u2019 expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Internal Med. 2015;175(2):274\u201386.","journal-title":"JAMA Internal Med"},{"issue":"4","key":"2539_CR125","doi-asserted-by":"publisher","first-page":"e010723","DOI":"10.1136\/bmjopen-2015-010723","volume":"6","author":"A Ghanouni","year":"2016","unstructured":"Ghanouni A, Meisel SF, Renzi C, Wardle J, Waller J. Survey of public definitions of the term \u201coverdiagnosis\u201d in the UK. BMJ Open. 2016;6(4):e010723.","journal-title":"BMJ Open"},{"issue":"5","key":"2539_CR126","doi-asserted-by":"publisher","first-page":"e0125165","DOI":"10.1371\/journal.pone.0125165","volume":"10","author":"R Moynihan","year":"2015","unstructured":"Moynihan R, Nickel B, Hersch J, Beller E, Doust J, Compton S, Barratt A, Bero L, McCaffery K. Public opinions about overdiagnosis: a national community survey. PLoS One. 2015;10(5):e0125165.","journal-title":"PLoS One"},{"issue":"12","key":"2539_CR127","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.2105\/AJPH.2014.302153","volume":"104","author":"SA Nowak","year":"2014","unstructured":"Nowak SA, Parker AM. Social network effects of nonlifesaving early-stage breast cancer detection on mammography rates. Am J Public Health. 2014;104(12):2439\u201344.","journal-title":"Am J Public Health"},{"issue":"12","key":"2539_CR128","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.healthpol.2018.09.013","volume":"122","author":"J Abelson","year":"2018","unstructured":"Abelson J, Tripp L, Sussman J. \u201cI just want to be able to make a choice\u201d: results from citizen deliberations about mammography screening in Ontario Canada. Health Policy. 2018;122(12):1364\u201371.","journal-title":"Health Policy"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02539-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-024-02539-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-024-02539-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T15:03:13Z","timestamp":1716908593000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-024-02539-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":128,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2539"],"URL":"https:\/\/doi.org\/10.1186\/s13643-024-02539-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3944490\/v1","asserted-by":"object"}]},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}